Advertisement

Opportunistic Parathyroid Gland Assessment on Routine CT Could Decrease Morbidity from Undiagnosed Primary Hyperparathyroidism

      Rationale and Objectives

      Gaps in primary hyperparathyroidism diagnosis are well-documented. End-organ damage correlates with disease duration and often occurs before diagnosis. We hypothesize that opportunistic parathyroid gland assessment on routine CT could decrease existing diagnosis gaps. Our purpose is to assess for enlarged parathyroid glands on contrast-enhanced CT acquired prior to biochemical screening and subsequent development of related morbidity.

      Materials and Methods

      This retrospective study included consecutive patients with primary hyperparathyroidism undergoing parathyroidectomy with contrast-enhanced CT including the lower neck and upper chest acquired prior to biochemical screening. One neuroradiologist retrospectively evaluated all CTs for enlarged (estimated weight greater than 60 mg) parathyroid glands. Gold standard operative and pathology reports were correlated with CT findings, and medical records were reviewed for development of primary hyperparathyroidism-related comorbidities.

      Results

      The sample comprised 38 patients (30 women, 8 men, median age 60 years) with 70 CTs of interest. The neuroradiologist identified 32 putative enlarged parathyroid glands (median estimated weight 307 mg) in 29 (76%) patients on CTs predating biochemical screening by a median of 30 months. Putative enlarged parathyroid glands on CT corresponded to pathologically proven parathyroid lesions in 26 (90%) patients. Of 26 patients with retrospectively identified pathologically proven parathyroid lesions, 12 (46%) developed at least 1 renal, bone, or neurocognitive comorbidity between CT and subsequent biochemical screening.

      Conclusion

      Enlarged parathyroid glands are frequently visible on routine CTs acquired years prior to primary hyperparathyroidism diagnosis. Biochemical screening based on enlarged glands could potentially prevent associated morbidity in almost half of such patients.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Academic Radiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Balentine CJ
        • Xie R
        • Kirklin JK
        • et al.
        Failure to diagnose hyperparathyroidism in 10,432 patients with hypercalcemia: opportunities for system-level intervention to increase surgical referrals and cure.
        Ann Surg. 2017; 266: 632-640
        • Alore EA
        • Suliburk JW
        • Ramsey DJ
        • et al.
        Diagnosis and management of primary hyperparathyroidism across the veterans affairs health care system.
        JAMA Intern Med. 2019; 179: 1220-1227https://doi.org/10.1001/jamainternmed.2019.1747
        • Nguyen-Lee JJ
        • Paciuc M
        • Guerra R
        • et al.
        Derivation of a cost-saving screening strategy for asymptomatic primary hyperparathyroidism.
        Surgery. 2020; 167: 155-159
        • Wilhelm SM
        • Wang TS
        • Ruan DT
        • et al.
        The American Association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism.
        JAMA Surg. 2016; 151: 959-968
        • Yu N
        • Donnan PT
        • Flynn RWV
        • et al.
        Increased mortality and morbidity in mild primary hyperparathyroid patients. The Parathyroid Epidemiology and Audit Research Study (PEARS).
        Clin Endocrinol (Oxf). 2010; 73: 30-34
        • Assadipour Y
        • Zhou H
        • Kuo EJ
        • et al.
        End-organ effects of primary hyperparathyroidism: A population-based study.
        Surgery. 2019; 165: 99-104
        • Bunch PM
        • Randolph GW
        • Brooks JA
        • et al.
        Parathyroid 4D CT: What the surgeon wants to know.
        Radiographics. 2020; 40: 1383-1394
        • Yeh R
        • Tay Y-KD
        • Dercle L
        • et al.
        A simple formula to estimate parathyroid weight on 4D-CT, predict pathologic weight, and diagnose parathyroid adenoma in patients with primary hyperparathyroidism.
        AJNR Am J Neuroradiol. 2020; 41: 1690-1697
        • Bunch PM
        • Dietzen MJ
        • Randle RW.
        Enlarged parathyroid glands on trauma computed tomography: Frequency and assessment for possible primary hyperparathyroidism.
        J Comput Assist Tomogr. 2021; 45: 926-931
        • Bunch PM
        • Pavlina AA
        • Lipford ME
        • et al.
        Dual-energy parathyroid 4D-CT: Improved discrimination of parathyroid lesions from thyroid tissue using noncontrast 40-keV virtual monoenergetic images.
        AJNR Am J Neuroradiol. 2021; 42: 2001-2008
        • Bunch PM
        • Goyal A
        • Valenzuela CD
        • et al.
        Parathyroid 4D CT in primary hyperparathyroidism: Exploration of size measurements for identifying multigland disease and guiding biochemically successful parathyroidectomy.
        AJR Am J Roentgenol. 2022; 218: 888-897
        • Yao K
        • Singer FR
        • Roth SI
        • et al.
        Weight of normal parathyroid glands in patients with parathyroid adenomas.
        J Clin Endocrinol Metab. 2004; 89: 3208-3213
        • Kunstman JW
        • Kirsch JD
        • Mahajan A
        • et al.
        Clinical review: Parathyroid localization and implications for clinical management.
        J Clin Endocrinol Metab. 2013; 98: 902-912
        • Zander D
        • Bunch PM
        • et al.
        • Expert Panel on Neurological Imaging
        ACR Appropriateness Criteria® Parathyroid Adenoma.
        J Am Coll Radiol. 2021; 18: S406-S422
        • Hunter GJ
        • Schellingerhout D
        • Vu TH
        • et al.
        Accuracy of four-dimensional CT for the localization of abnormal parathyroid glands in patients with primary hyperparathyroidism.
        Radiology. 2012; 264: 789-795
        • Bahl M
        • Muzaffar M
        • Vij G
        • et al.
        Prevalence of the polar vessel sign in parathyroid adenomas on the arterial phase of 4D CT.
        AJNR Am J Neuroradiol. 2014; 35: 578-581
        • Hoang JK
        • Sung W
        • Bahl M
        • et al.
        How to perform parathyroid 4D CT: Tips and traps for technique and interpretation.
        Radiology. 2014; 270: 15-24
        • Bahl M
        • Sepahdari AR
        • Sosa JA
        • et al.
        Parathyroid adenomas and hyperplasia on four-dimensional CT scans: Three patterns of enhancement relative to the thyroid gland justify a three-phase protocol.
        Radiology. 2015; 277: 454-462
        • Hunter GJ
        • Ginat DT
        • Kelly HR
        • et al.
        Discriminating parathyroid adenoma from local mimics by using inherent tissue attenuation and vascular information obtained with four-dimensional CT: Formulation of a multinomial logistic regression model.
        Radiology. 2014; 270: 168-175
        • Kelly HR
        • Bunch PM.
        Parathyroid computed tomography: pearls, pitfalls, and our approach.
        Neuroimaging Clin N Am. 2022; 32: 413-431
      1. Werenski H, Nguyen C, Johansson E, et al. Can old imaging alter the preoperative and operative course of patients undergoing parathyroidectomy for primary hyperparathyroidism? Scientific abstract presented at Academic Surgical Conference 17th Annual Meeting; February 2022; Orlando, Florida.

        • Bilezikian JP
        • Brandi ML
        • Eastell R
        • et al.
        Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop.
        J Clin Endocrinol Metab. 2014; 99: 3561-3569
        • Pandian TK
        • Lubitz CC
        • Bird SH
        • et al.
        Normocalcemic hyperparathyroidism: A collaborative endocrine surgery quality improvement program analysis.
        Surgery. 2020; 167: 168-172
        • Sacks BA
        • Pallotta JA
        • Cole A
        • et al.
        Diagnosis of parathyroid adenomas: efficacy of measuring parathormone levels in needle aspirates of cervical masses.
        AJR Am J Roentgenol. 1994; 163: 1223-1226
        • Stephen AE
        • Milas M
        • Garner CN
        • et al.
        Use of surgeon-performed office ultrasound and parathyroid fine needle aspiration for complex parathyroid localization.
        Surgery. 2005; 138 (discussion 1150-1)
        • Erbil Y
        • Salmaslioğlu A
        • Kabul E
        • et al.
        Use of preoperative parathyroid fine-needle aspiration and parathormone assay in the primary hyperparathyroidism with concomitant thyroid nodules.
        Am J Surg. 2007; 193: 665-671
        • Abraham D
        • Sharma PK
        • Bentz J
        • et al.
        Utility of ultrasound-guided fine-needle aspiration of parathyroid adenomas for localization before minimally invasive parathyroidectomy.
        Endocr Pract. 2007; 13: 333-337